Tracing pesticide dynamics: High resolution offers new insights to karst groundwater quality.

Generally, karst aquifers and springs are highly susceptible to contamination due to the high permeability and, therefore, groundwater flow velocities. The often thin soil cover, accompanied by dolines, can lead to fast infiltration of precipitation water loaded with mobilized contaminants such as pesticides and their transformation products. To date, continuous, temporally highly resolved in-situ monitoring to decipher concentration dynamics for a broad range of pesticides is missing.

Closing the gap: Ion chromatography coupled to high-resolution mass spectrometry to trace highly polar anionic substances in groundwater.

Persistent, mobile and toxic (PMT), and very persistent and very mobile (vPvM) substances pose a threat to the water cycle but are often not covered in conventional environmental monitoring programs. Within this realm of substances, one compound class of concern are pesticides and their transformation products as they are deliberately introduced into the environment. To detect very polar anionic substances, including many pesticide transformation products with log D values ranging between -7.

Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses.

Background And Aims: Lipoprotein(a) (Lp(a)) is associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD). Our goal was to characterize patients undergoing Lp(a) testing and to assess the impact of Lp(a) testing on treatment changes and subsequent ASCVD events.

Methods: A cross-sectional and a longitudinal claims data analysis were performed on 4 million patient records in Germany.

Rationale and study design of OUTSTEP-HF: a randomised controlled study to assess the effect of sacubitril/valsartan and enalapril on physical activity measured by accelerometry in patients with heart failure with reduced ejection fraction.

Aim: In PARADIGM-HF, sacubitril/valsartan demonstrated superiority to enalapril in reducing mortality and morbidity in patients with heart failure (HF) with reduced ejection fraction (HFrEF). Several patient-centred outcomes like improved physical activity and quality of life have been emphasised as important treatment goals in HF management. OUTSTEP-HF has been designed to evaluate the effect of sacubitril/valsartan compared with enalapril on non-sedentary daytime physical activity in patients with HFrEF.